Neuroprotective effect of combination of poly (ADP-ribose) polymerase inhibitor and antioxidant in middle cerebral artery occlusion induced focal ischemia in rats

Neurological Research

Volumn 26, Issue 1, 2004, Pages 103-107

  Gupta, Saurabh ^a   Kaul, Chaman L ^a   Sharma, Shyam S ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

3 aminobenzamide; Antioxidant; Combination; Focal ischemia; Melatonin; Nicotinamide; Poly (ADP ribose) polymerase inhibitor; Rat

Indexed keywords

3 AMINOBENZAMIDE; ANTIOXIDANT; MELATONIN; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; POLYLYSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG MIXTURE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; RAT; REPERFUSION; SCORING SYSTEM; STROKE;

ANIMALS; ANTIOXIDANTS; BENZAMIDES; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MELATONIN; NEUROPROTECTIVE AGENTS; NIACINAMIDE; POLY(ADP-RIBOSE) POLYMERASES; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 0842332392     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164104773026624     Document Type: Article

References (23)

1. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999; 79: 1431-1568
2. Schmid-Elsaesser R, Hungerhuber E, Zausinger S, Baethmann A, Reulen HJ. Combination drug therapy and mild hypothermia: A promising treatment strategy for reversible, focal cerebral ischemia. Stroke 1999, 30: 1891-1899
3. Schmid-Elsaesser R, Zausinger S, Hungerhuber F, Baethmann A, Reulen HJ. Neuroprotective effect of combination therapy with tirilazad and magnesium in rat subjected to reversible focal cerebral ischemia. Neurosurg 1999; 44: 163-172
4. Spinnewyn B, Cornet S, Auguet M, Chabrier PE. Synergistic protective effects of antioxidant and nitric oxide synthase inhibitors in transient focal ischemia. J Cereb Blood Flow Metab 1999; 19: 139-143
5. Belayev L, Alonso OF, Busto R, Zhao W, Ginsburg MD. Middle cerebral artery occlusion in the rat by intraluminal suture: Neurological and pathological evaluation of improved model. Stroke 1996; 27: 1616-1623
6. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Barthkowski H. Rat middle cerebral artery occlusion: Evaluation of the model and development of neurological examination. Stroke 1986; 17: 472-476
7. Takahashi K, Greenberg JH. The effect of reperfusion on neuroprotection using an inhibitor of poly(ADP-ribose) polymerase. NeuroReport 1999; 10: 2017-2022
8. Tokime T, Nozaki K, Sugino T, Kikuchi H, Hashimoto N, Ueda K. Enhanced poly (ADP-ribosyl)ation after focal ischemia in rat brain. J Cereb Blood Flow Metab 1998; 18: 991-997
9. Mokudai T, Ayoub IA, Sakakibara Y, Lee EJ, Ogilvy CS, Maynard KI. Delayed treatment with nicotinamide (Vitamin B(3)) improves neurological outcome and reduces infarct volume after transient focal cerebral ischemia in Wistar rats. Stroke 2000; 7: 1679-1685
10. Ayoub IA, Maynard KI. Therapeutic window for nicotinamide following transient focal cerebral ischemia. NeuroReport 2002; 13: 213-216
11. Virag L, Szabo C. The therapeutic potential of poly (ADP-ribose) inhibitors. Pharmacol Rev 2002; 54: 375-429
12. Sakakibara Y, Mitha AP, Ayoub IA, Ogilvy CS, Maynard KI. Delayed treatment with nicotinamide (vitamin B3) reduces the infarct volume following focal cerebral ischemia in spontaneously hypertensive rats, diabetic and non-diabetic Fischer 344 rats. Brain Res 2002; 931: 68-73
13. Yang J, Klaidman LK, Nalbandian A, Oliver J, Chang ML, Chan PH, Adams JD Jr. The effects of nicotinamide on energy metabolism following transient focal cerebral ischemia in Wistar rats. Neurosci Lett 2002; 333: 91-94
14. Yang J, Klaidman LK, Chang ML, Kem S, Sugawara T, Chan P, Adams JD. Nicotinamide therapy protects against both necrosis and apoptosis in a stroke model. Pharmacol Biochem Behav 2002; 73: 901-910
15. Huang TF, Chao CC. The effect of nicotinamide on cerebral circulation. Proc Soc Exp Biol Med 1960; 105: 551-553
16. Pei Z, Pang SF, Cheung RT. Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. Stroke 2003; 34: 770-775
17. Sinha K, Degaonkar MN, Jagannathan N, Gupta YK. Effect of melatonin on ischemia reperfusion injury induced by middle cerebral artery occlusion in rats. Eur J Pharmacol 2001; 428: 185-192
18. Skaper SD, Floreani M, Ceccon M, Facci L, Giusti P. Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin. Ann NY Acad Sci 1999; 890: 107-108
19. Guerrero JM, Reiter RJ, Ortiz GG, Pablos MI, Sewerynek E, Chuang JI. Melatonin prevents increases in neural nitric oxide and cyclic GMP production after transient brain ischemia and reperfusion in the Mongolian gerbil (Meriones unguiculatus). J Pineal Res 1997; 23: 24-31
20. Regrigny O, Delagrange P, Scalbert E, Atkinson J, Lartaud-Idjouadiene I. Melatonin improves cerebral circulation security margin in rats. Am J Physiol 1998; 275: H139-H144
21. Fiorina P, Lattuada G, Silvestrini C, Ponari O, Dall'Aglio P. Disruption of nocturnal melatonin rhythm and immunological involvement in ischaemic stroke patients. Scand J Immunol 1999; 50: 228-231
22. Kilic E, Ozdemir YG, Bolay H, Kelestimur H, Dalkara T. Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischaemia. J Cereb Blood Flow Metab 1999; 19: 511-516
23. Reiter RJ. Antioxidant actions of melatonin. Adv Pharmacol 1997; 38: 103-117